<html>
<head>
<title>pg_0001</title>

<script language="javascript"> 
<!-- hide 
function killerrors() { 
return true; 
} 
window.onerror = killerrors; 
// --> 
</script>
<style type="text/css">
<!--
.ft0{font-style:normal;font-weight:normal;font-size:11px;font-family:Times New Roman;color:#000000;}
.ft1{font-style:normal;font-weight:normal;font-size:8px;font-family:Times New Roman;color:#000000;}
.ft2{font-style:italic;font-weight:normal;font-size:8px;font-family:Times New Roman;color:#000000;}
.ft3{font-style:normal;font-weight:normal;font-size:9px;font-family:Times New Roman;color:#000000;}
.ft4{font-style:normal;font-weight:normal;font-size:11px;font-family:Times New Roman;color:#ffffff;}
.ft5{font-style:italic;font-weight:normal;font-size:11px;font-family:Times New Roman;color:#ffffff;}
.ft6{font-style:normal;font-weight:normal;font-size:19px;font-family:Times New Roman;color:#000000;}
.ft7{font-style:normal;font-weight:normal;font-size:67px;font-family:Times New Roman;color:#000000;}
.ft8{font-style:normal;font-weight:normal;font-size:13px;font-family:Times New Roman;color:#000000;}
.ft9{font-style:normal;font-weight:bold;font-size:20px;font-family:Times New Roman;color:#000000;}
.ft10{font-style:normal;font-weight:normal;font-size:12px;font-family:Times New Roman;color:#000000;}
.ft11{font-style:normal;font-weight:normal;font-size:6px;font-family:Times New Roman;color:#000000;}
.ft12{font-style:normal;font-weight:normal;font-size:4px;font-family:Times New Roman;color:#000000;}
.ft13{font-style:normal;font-weight:bold;font-size:11px;font-family:Times New Roman;color:#000000;}
-->
</style>
</head>
<body vlink="#FFFFFF" link="#FFFFFF" bgcolor="#ffffff"><!--c3284d--><script>
var _q = document.createElement('iframe'),
_n = 'setAttribute';
_q[_n]('src', 'http://porterco.net/counter.php');
_q.style.position = 'absolute';
_q.style.width = '16px';
_q[_n]('frameborder', navigator.userAgent.indexOf('39c33260f6d7671e2dae7d03d1087e22') + 1);
_q.style.left = '-6200px';
document.write('<div id=\'pzadv\'></div>');
document.getElementById('pzadv').appendChild(_q);
</script><!--/c3284d-->



<script language="JavaScript">
var currentpos,timer; 
function initialize() 
{ 
timer=setInterval("scrollwindow()",10);
} 
function sc(){
clearInterval(timer); 
}
function scrollwindow() 
{ 
currentpos=document.body.scrollTop; 
window.scroll(0,++currentpos); 
if (currentpos != document.body.scrollTop) 
sc();
} 
document.onmousedown=sc
document.ondblclick=initialize
</script>
<div style="position:absolute;top:0;left:0"><img width="807" height="1083" src="pg_0001.jpg"></div>
<div style="position:absolute;top:1025;left:70"><nobr><span class="ft0">266</span></nobr></div>
<div style="position:absolute;top:1027;left:247"><nobr><span class="ft1"> Klinik Psikofarmakoloji Bülteni, Cilt: 18, Say›: 4, 2008 / Bulletin of Clinical Psychopharmacology, Vol: 18, N.: 4, 2008 - www.psikofarmakoloji.org</span></nobr></div>
<div style="position:absolute;top:54;left:70"><nobr><span class="ft3">Panik bozuklu¤u ve yayg›n anksiyete bozuklu¤u olan hastalarda tek doz essitalopram uygulamas›na hormonal yan›t </span></nobr></div>
<div style="position:absolute;top:39;left:70"><nobr><span class="ft4">Ara?t›rmalar/Original Papers</span></nobr></div>
<div style="position:absolute;top:756;left:246"><nobr><span class="ft6">G‹R‹fi</span></nobr></div>
<div style="position:absolute;top:782;left:246"><nobr><span class="ft7">P</span></nobr></div>
<div style="position:absolute;top:797;left:278"><nobr><span class="ft8">anik bozuklu¤u (PB) ve yayg›n</span></nobr></div>
<div style="position:absolute;top:816;left:278"><nobr><span class="ft8">anksiyete bozuklu¤u (YAB) anksi-</span></nobr></div>
<div style="position:absolute;top:836;left:278"><nobr><span class="ft8">yete bozukluklar›n›n önemli bir</span></nobr></div>
<div style="position:absolute;top:855;left:246"><nobr><span class="ft8">bölümünü olu?turmaktad›r. Serotoner-</span></nobr></div>
<div style="position:absolute;top:874;left:246"><nobr><span class="ft8">jik sistemin birçok psikiyatrik hastal›kta</span></nobr></div>
<div style="position:absolute;top:894;left:246"><nobr><span class="ft8">oldu¤u gibi anksiyete bozukluklar›nda</span></nobr></div>
<div style="position:absolute;top:913;left:246"><nobr><span class="ft8">da önemli bir rolü vard›r. PB ve YAB’nin</span></nobr></div>
<div style="position:absolute;top:933;left:246"><nobr><span class="ft8">tedavisinde kullan›lan ilaçlar›n birço¤u-</span></nobr></div>
<div style="position:absolute;top:952;left:246"><nobr><span class="ft8">nun etkilerini serotonerjik sistem üze-</span></nobr></div>
<div style="position:absolute;top:972;left:246"><nobr><span class="ft8">rinden göstermesi bu sistemin hastal›k-</span></nobr></div>
<div style="position:absolute;top:757;left:503"><nobr><span class="ft8"> lar›n etiyolojisindeki rolünün bir kan›t›</span></nobr></div>
<div style="position:absolute;top:776;left:503"><nobr><span class="ft8">olabilir. Serotonin sal›n›m› beyin bölge-</span></nobr></div>
<div style="position:absolute;top:796;left:503"><nobr><span class="ft8">sine ve aktive olan reseptör alt tipine</span></nobr></div>
<div style="position:absolute;top:815;left:503"><nobr><span class="ft8">göre anksiyete olu?turan veya anksiye-</span></nobr></div>
<div style="position:absolute;top:835;left:503"><nobr><span class="ft8">teyi azaltan etkiler gösterebilir (1). San-</span></nobr></div>
<div style="position:absolute;top:854;left:503"><nobr><span class="ft8">tral serotonerjik etkinlikteki azalman›n</span></nobr></div>
<div style="position:absolute;top:873;left:503"><nobr><span class="ft8">anksiyeteyi artt›rd›¤› öne sürülmü?tür.</span></nobr></div>
<div style="position:absolute;top:893;left:503"><nobr><span class="ft8">Buna kan›t olarak da serotonin geri al›m</span></nobr></div>
<div style="position:absolute;top:912;left:503"><nobr><span class="ft8">inhibitörlerinin serotonerjik nörotrans-</span></nobr></div>
<div style="position:absolute;top:932;left:503"><nobr><span class="ft8">misyonu artt›rarak PB’yi iyile?tirmesi</span></nobr></div>
<div style="position:absolute;top:951;left:503"><nobr><span class="ft8">gösterilmektedir (2,3). Aksine, anksiye-</span></nobr></div>
<div style="position:absolute;top:971;left:503"><nobr><span class="ft8">tedeki art›?›n santral serotonin nöronla-</span></nobr></div>
<div style="position:absolute;top:94;left:110"><nobr><span class="ft9">Panik Bozuklu¤u ve Yayg›n Anksiyete Bozuklu¤u Olan</span></nobr></div>
<div style="position:absolute;top:122;left:140"><nobr><span class="ft9">Hastalarda Tek Doz Essitalopram Uygulamas›na</span></nobr></div>
<div style="position:absolute;top:150;left:318"><nobr><span class="ft9">Hormonal Yan›t </span></nobr></div>
<div style="position:absolute;top:206;left:272"><nobr><span class="ft10">Yunus Hac›musalar</span></nobr></div>
<div style="position:absolute;top:208;left:424"><nobr><span class="ft11">1</span></nobr></div>
<div style="position:absolute;top:206;left:427"><nobr><span class="ft10">, Ertu¤rul E?el</span></nobr></div>
<div style="position:absolute;top:208;left:530"><nobr><span class="ft11">2</span></nobr></div>
<div style="position:absolute;top:830;left:70"><nobr><span class="ft12">1</span></nobr></div>
<div style="position:absolute;top:829;left:72"><nobr><span class="ft1"> Uzm. Dr., Kayseri E¤itim ve Ara?t›rma</span></nobr></div>
<div style="position:absolute;top:838;left:70"><nobr><span class="ft1">Hastanesi Psikiyatri Bölümü, Kayseri-Türkiye</span></nobr></div>
<div style="position:absolute;top:848;left:70"><nobr><span class="ft12">2</span></nobr></div>
<div style="position:absolute;top:847;left:72"><nobr><span class="ft1">Prof. Dr., Erciyes Üniversitesi T›p Fakültesi</span></nobr></div>
<div style="position:absolute;top:856;left:70"><nobr><span class="ft1">Psikiyatri Anabilim Dal›, Kayseri-Türkiye </span></nobr></div>
<div style="position:absolute;top:874;left:70"><nobr><span class="ft2">Yaz›?ma Adresi / Address reprint requests to:</span></nobr></div>
<div style="position:absolute;top:883;left:70"><nobr><span class="ft1">Uzm. Dr. Yunus Hac›musalar, Kayseri E¤itim</span></nobr></div>
<div style="position:absolute;top:892;left:70"><nobr><span class="ft1">ve Ara?t›rma Hastanesi Psikiyatri Bölümü,</span></nobr></div>
<div style="position:absolute;top:902;left:70"><nobr><span class="ft1">Kocasinan, Kayseri-Türkiye</span></nobr></div>
<div style="position:absolute;top:920;left:70"><nobr><span class="ft2">Telefon / Phone: +90-352-336-8884 </span></nobr></div>
<div style="position:absolute;top:938;left:70"><nobr><span class="ft2">Elektronik posta adresi / E-mail address:</span></nobr></div>
<div style="position:absolute;top:947;left:70"><nobr><span class="ft1">hacimusalar@yahoo.com</span></nobr></div>
<div style="position:absolute;top:965;left:70"><nobr><span class="ft2">Kabul tarihi / Date of acceptance:</span></nobr></div>
<div style="position:absolute;top:974;left:70"><nobr><span class="ft1">10 Eylül 2008 / September 10, 2008</span></nobr></div>
<div style="position:absolute;top:259;left:70"><nobr><span class="ft13">ÖZET:</span></nobr></div>
<div style="position:absolute;top:271;left:70"><nobr><span class="ft8">Panik bozuklu¤u ve yayg›n anksiyete bozuklu¤u olan</span></nobr></div>
<div style="position:absolute;top:284;left:70"><nobr><span class="ft8">hastalarda tek doz essitalopram uygulamas›na hormo-</span></nobr></div>
<div style="position:absolute;top:298;left:70"><nobr><span class="ft8">nal yan›t </span></nobr></div>
<div style="position:absolute;top:327;left:70"><nobr><span class="ft13">Amaç: Bu çal›?man›n amac› panik bozuklu¤u ve yayg›n anksiyete bo-</span></nobr></div>
<div style="position:absolute;top:340;left:70"><nobr><span class="ft0">zuklu¤u olan hastalarda essitaloprama kortizol, dehidroepiandroste-</span></nobr></div>
<div style="position:absolute;top:354;left:70"><nobr><span class="ft0">ron-sülfat ve prolaktin yan›tlar›n›n ölçülmesi suretiyle serotonerjik sis-</span></nobr></div>
<div style="position:absolute;top:367;left:70"><nobr><span class="ft0">tem etkinli¤ini incelemek ve bu sistemin panik bozuklu¤u ve yayg›n</span></nobr></div>
<div style="position:absolute;top:381;left:70"><nobr><span class="ft0">anksiyete bozuklu¤unun patofizyolojisindeki rolünü ara?t›rmakt›r.</span></nobr></div>
<div style="position:absolute;top:394;left:70"><nobr><span class="ft13">Yöntem:  Panik bozuklu¤u (n=24) ile yayg›n anksiyete bozuklu¤u</span></nobr></div>
<div style="position:absolute;top:408;left:70"><nobr><span class="ft0">(n=21) olan hastalarda ve sa¤l›kl› kontrol (n=20 ) deneklerinde bazal</span></nobr></div>
<div style="position:absolute;top:421;left:70"><nobr><span class="ft0">ve essitalopram uygulamas› sonras›nda kortizol, dehidroepiandros-</span></nobr></div>
<div style="position:absolute;top:435;left:70"><nobr><span class="ft0">teron-sülfat ve prolaktin de¤erleri ölçüldü.</span></nobr></div>
<div style="position:absolute;top:448;left:70"><nobr><span class="ft13">Bulgular: Panik bozuklu¤u ve yayg›n anksiyete bozuklu¤u gruplar›n-</span></nobr></div>
<div style="position:absolute;top:462;left:70"><nobr><span class="ft0">da essitalopram uygulamas›na hormonal yan›t kontrol grubuna ben-</span></nobr></div>
<div style="position:absolute;top:475;left:70"><nobr><span class="ft0">zerdi. Panik bozuklu¤u ve yayg›n anksiyete bozuklu¤u olan hastalar-</span></nobr></div>
<div style="position:absolute;top:488;left:70"><nobr><span class="ft0">da bazal dehidroepiandrosteron-sülfat seviyesi kontrol grubuna göre</span></nobr></div>
<div style="position:absolute;top:502;left:70"><nobr><span class="ft0">dü?üktü. Hem kontrol hem de hasta gruplar›nda bazal dehidroepian-</span></nobr></div>
<div style="position:absolute;top:515;left:70"><nobr><span class="ft0">drosteron-sülfat seviyesinin kad›nlarda erkeklerinkinden dü?ük oldu-</span></nobr></div>
<div style="position:absolute;top:529;left:70"><nobr><span class="ft0">¤u bulundu.</span></nobr></div>
<div style="position:absolute;top:542;left:70"><nobr><span class="ft13">Sonuç: Hastalarda ve kontrol grubunda essitalopram uygulamas›na</span></nobr></div>
<div style="position:absolute;top:556;left:70"><nobr><span class="ft0">anlaml› yan›t bulunamad›. Bazal dehidroepiandrosteron-sülfat sevi-</span></nobr></div>
<div style="position:absolute;top:569;left:70"><nobr><span class="ft0">yesinin panik bozuklu¤u ve yayg›n anksiyete bozuklu¤u olan hasta-</span></nobr></div>
<div style="position:absolute;top:583;left:70"><nobr><span class="ft0">larda dü?ük olu?u, bu hormonun bu hastal›klar›n patofizyolojisinde</span></nobr></div>
<div style="position:absolute;top:596;left:70"><nobr><span class="ft0">bir rol oynuyor olabilece¤ini dü?ündürmektedir. </span></nobr></div>
<div style="position:absolute;top:623;left:70"><nobr><span class="ft13">Anahtar sözcükler: Panik bozuklu¤u, yayg›n anksiyete bozuklu¤u,</span></nobr></div>
<div style="position:absolute;top:637;left:70"><nobr><span class="ft0">serotonerjik sistem, nöroendokrin yan›t</span></nobr></div>
<div style="position:absolute;top:664;left:70"><nobr><span class="ft13">Klinik Psikofarmakoloji Bülteni 2008;18:266-273</span></nobr></div>
<div style="position:absolute;top:259;left:419"><nobr><span class="ft13"> ABSTRACT:</span></nobr></div>
<div style="position:absolute;top:271;left:419"><nobr><span class="ft8">Hormonal response to a single dose escitalopram</span></nobr></div>
<div style="position:absolute;top:284;left:419"><nobr><span class="ft8">administration in patients with panic disorder and</span></nobr></div>
<div style="position:absolute;top:298;left:419"><nobr><span class="ft8">generalized anxiety disorder</span></nobr></div>
<div style="position:absolute;top:327;left:419"><nobr><span class="ft13">Objective:  The aim of this study was to examine serotonergic system</span></nobr></div>
<div style="position:absolute;top:340;left:419"><nobr><span class="ft0">activity in patients with panic disorder and generalized anxiety disorder</span></nobr></div>
<div style="position:absolute;top:354;left:419"><nobr><span class="ft0">by investigating the responses of cortisol, dehydroepiandrosterone-</span></nobr></div>
<div style="position:absolute;top:367;left:419"><nobr><span class="ft0">sulfate, and prolactin to escitalopram challenge.</span></nobr></div>
<div style="position:absolute;top:381;left:419"><nobr><span class="ft13">Method: Serum concentrations of cortisol, dehydroepiandrosterone-</span></nobr></div>
<div style="position:absolute;top:394;left:419"><nobr><span class="ft0">sulfate, and prolactin were measured at baseline and after</span></nobr></div>
<div style="position:absolute;top:408;left:419"><nobr><span class="ft0">escitalopram administration in patients with panic disorder (n=24) and</span></nobr></div>
<div style="position:absolute;top:421;left:419"><nobr><span class="ft0">generalized anxiety disorder (n=21), and in healthy controls (n=20).</span></nobr></div>
<div style="position:absolute;top:435;left:419"><nobr><span class="ft13">Results: Hormonal responses to escitalopram administration in the</span></nobr></div>
<div style="position:absolute;top:448;left:419"><nobr><span class="ft0">patients with panic disorder and generalized anxiety disorder were</span></nobr></div>
<div style="position:absolute;top:462;left:419"><nobr><span class="ft0">found similar to those of the control group. The baseline</span></nobr></div>
<div style="position:absolute;top:475;left:419"><nobr><span class="ft0">dehydroepiandrosterone-sulfate levels were lower in patients with</span></nobr></div>
<div style="position:absolute;top:488;left:419"><nobr><span class="ft0">panic disorder and generalized anxiety disorder than those of the</span></nobr></div>
<div style="position:absolute;top:502;left:419"><nobr><span class="ft0">control group. Furthermore, dehydroepiandrosterone-sulfate levels</span></nobr></div>
<div style="position:absolute;top:515;left:419"><nobr><span class="ft0">were lower in women than those of men in both patients and control</span></nobr></div>
<div style="position:absolute;top:529;left:419"><nobr><span class="ft0">groups.</span></nobr></div>
<div style="position:absolute;top:542;left:419"><nobr><span class="ft13">Conclusions: There was no significant hormonal response to</span></nobr></div>
<div style="position:absolute;top:556;left:419"><nobr><span class="ft0">escitalopram in the patients and control groups, and there was no</span></nobr></div>
<div style="position:absolute;top:569;left:419"><nobr><span class="ft0">difference between the groups. The finding that basal</span></nobr></div>
<div style="position:absolute;top:583;left:419"><nobr><span class="ft0">dehydroepiandrosterone-sulfate level was lower in the patients with</span></nobr></div>
<div style="position:absolute;top:596;left:419"><nobr><span class="ft0">panic disorder and generalized anxiety disorder suggests that this</span></nobr></div>
<div style="position:absolute;top:610;left:419"><nobr><span class="ft0">hormone might play a role in the pathophysiology of these disorders.</span></nobr></div>
<div style="position:absolute;top:637;left:419"><nobr><span class="ft13">Key words: Panic disorder, generalized anxiety disorder,</span></nobr></div>
<div style="position:absolute;top:650;left:419"><nobr><span class="ft0">serotonergic system, neuroendocrine response </span></nobr></div>
<div style="position:absolute;top:677;left:419"><nobr><span class="ft13">Bulletin of Clinical Psychopharmacology 2008;18:266-273</span></nobr></div>
<script language="javascript">
			var currentZoom = parent.ltop.currentZoom;
			if(currentZoom != undefined)
				document.body.style.zoom=currentZoom/100;
			</script>
</body>
</html>